The legacy success of sildenafil has undeniably shaped the drug landscape. However, wagering in companies heavily reliant on biosimilars and the waning patent exclusivity surrounding this flagship https://bookmarksden.com/story21562658/sildenafil-and-pharma-a-speculative-opportunity